663 related articles for article (PubMed ID: 32764200)
1. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
Klein SL; Pekosz A; Park HS; Ursin RL; Shapiro JR; Benner SE; Littlefield K; Kumar S; Naik HM; Betenbaugh MJ; Shrestha R; Wu AA; Hughes RM; Burgess I; Caturegli P; Laeyendecker O; Quinn TC; Sullivan D; Shoham S; Redd AD; Bloch EM; Casadevall A; Tobian AA
J Clin Invest; 2020 Nov; 130(11):6141-6150. PubMed ID: 32764200
[TBL] [Abstract][Full Text] [Related]
2. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
Klein S; Pekosz A; Park HS; Ursin R; Shapiro J; Benner S; Littlefield K; Kumar S; Naik HM; Betenbaugh M; Shrestha R; Wu A; Hughes R; Burgess I; Caturegli P; Laeyendecker O; Quinn T; Sullivan D; Shoham S; Redd A; Bloch E; Casadevall A; Tobian A
medRxiv; 2020 Jun; ():. PubMed ID: 32607519
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
[TBL] [Abstract][Full Text] [Related]
4. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
Beaudoin-Bussières G; Laumaea A; Anand SP; Prévost J; Gasser R; Goyette G; Medjahed H; Perreault J; Tremblay T; Lewin A; Gokool L; Morrisseau C; Bégin P; Tremblay C; Martel-Laferrière V; Kaufmann DE; Richard J; Bazin R; Finzi A
mBio; 2020 Oct; 11(5):. PubMed ID: 33067385
[TBL] [Abstract][Full Text] [Related]
5. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
6. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
[TBL] [Abstract][Full Text] [Related]
7. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
Zhang L; Pang R; Xue X; Bao J; Ye S; Dai Y; Zheng Y; Fu Q; Hu Z; Yi Y
Aging (Albany NY); 2020 Apr; 12(8):6536-6542. PubMed ID: 32320384
[TBL] [Abstract][Full Text] [Related]
8. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
Bradfute SB; Hurwitz I; Yingling AV; Ye C; Cheng Q; Noonan TP; Raval JS; Sosa NR; Mertz GJ; Perkins DJ; Harkins MS
J Infect Dis; 2020 Oct; 222(10):1620-1628. PubMed ID: 32779705
[TBL] [Abstract][Full Text] [Related]
9. Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020.
Mehew J; Johnson R; Roberts D; Harvala H
Euro Surveill; 2020 Nov; 25(45):. PubMed ID: 33183404
[TBL] [Abstract][Full Text] [Related]
10. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.
Li C; Yu D; Wu X; Liang H; Zhou Z; Xie Y; Li T; Wu J; Lu F; Feng L; Mao M; Lin L; Guo H; Yue S; Wang F; Peng Y; Hu Y; Wang Z; Yu J; Zhang Y; Lu J; Ning H; Yang H; Fu D; He Y; Zhou D; Du T; Duan K; Dong D; Deng K; Zou X; Zhang Y; Zhou R; Gao Y; Zhang X; Yang X
Nat Commun; 2021 Jul; 12(1):4144. PubMed ID: 34230476
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
[TBL] [Abstract][Full Text] [Related]
12. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J
JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970
[TBL] [Abstract][Full Text] [Related]
14. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.
Wendel S; Kutner JM; Machado R; Fontão-Wendel R; Bub C; Fachini R; Yokoyama A; Candelaria G; Sakashita A; Achkar R; Hamerschlak N; Scuracchio P; Amaral M; Dal Ben M; Araujo D; Soares C; Camargo A; Kallás E; Durigon E; Reis LF; Rizzo LV
Transfusion; 2020 Dec; 60(12):2938-2951. PubMed ID: 32935877
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
Deshpande GR; Sapkal GN; Tilekar BN; Yadav PD; Gurav Y; Gaikwad S; Kaushal H; Deshpande KS; Kaduskar O; Sarkale P; Baradkar S; Suryawanshi A; Lakra R; Sugunan AP; Balakrishnan A; Abraham P; Salve P
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):82-87. PubMed ID: 32859866
[TBL] [Abstract][Full Text] [Related]
16. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
[TBL] [Abstract][Full Text] [Related]
17. Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
Kalkan Yazıcı M; Koç MM; Çetin NS; Karaaslan E; Okay G; Durdu B; Sümbül B; Doymaz MZ
J Immunol; 2020 Nov; 205(10):2719-2725. PubMed ID: 32978281
[TBL] [Abstract][Full Text] [Related]
18. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
Isho B; Abe KT; Zuo M; Jamal AJ; Rathod B; Wang JH; Li Z; Chao G; Rojas OL; Bang YM; Pu A; Christie-Holmes N; Gervais C; Ceccarelli D; Samavarchi-Tehrani P; Guvenc F; Budylowski P; Li A; Paterson A; Yue FY; Marin LM; Caldwell L; Wrana JL; Colwill K; Sicheri F; Mubareka S; Gray-Owen SD; Drews SJ; Siqueira WL; Barrios-Rodiles M; Ostrowski M; Rini JM; Durocher Y; McGeer AJ; Gommerman JL; Gingras AC
Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033173
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
[TBL] [Abstract][Full Text] [Related]
20. Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
Boonyaratanakornkit J; Morishima C; Selke S; Zamora D; McGuffin S; Shapiro AE; Campbell VL; McClurkan CL; Jing L; Gross R; Liang J; Postnikova E; Mazur S; Lukin VV; Chaudhary A; Das MK; Fink SL; Bryan A; Greninger AL; Jerome KR; Holbrook MR; Gernsheimer TB; Wener MH; Wald A; Koelle DM
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33320842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]